Sabre (SABR): Constellation’s most asymmetric bet
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Dear $AMC Apes. Your favorite stock is cheaper than last week. Maybe it is time to buy more.
$SHOE is going to get interesting:
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
FRMI · long Fermi Inc. is presented as a time-sensitive long special situation.
Bill Ackman opens a Pershing Square webcast with a film featuring former Herbalife distributors, followed by a panel moderated by MLM…
Bill Ackman discusses Pershing Square’s campaign at JCPenney after his resignation from its board, defending Ron Johnson’s strategy while…
Bill Ackman and Carl Icahn’s 2013 CNBC clash over Herbalife preceded Icahn’s $1 billion-plus exit and Ackman’s loss on the stock.
Bill Ackman discusses his more than $1 billion short position in Herbalife in a CNN interview.
Carl Icahn recounts Texaco’s purchase of Getty Oil after Getty had reached an agreement with Pennzoil, the resulting Texas verdict against…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.